| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0969-8051(98)00053-5 |
| P698 | PubMed publication ID | 9863555 |
| P50 | author | Christer Halldin | Q62559921 |
| P2093 | author name string | Sedvall G | |
| Hall H | |||
| Farde L | |||
| P2860 | cites work | Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin | Q24564132 |
| Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain | Q28235437 | ||
| [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography | Q28276154 | ||
| Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist | Q28288751 | ||
| Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography | Q37690625 | ||
| Chemical brain anatomy in schizophrenia | Q40473365 | ||
| Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primates | Q48255964 | ||
| Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride | Q48301941 | ||
| [11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations | Q48308739 | ||
| Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. | Q48385577 | ||
| Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study | Q48539838 | ||
| [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain | Q48602714 | ||
| Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum | Q48612095 | ||
| In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain | Q48701361 | ||
| NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors | Q48827053 | ||
| Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. | Q48848853 | ||
| [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography | Q49018737 | ||
| Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635 | Q57535487 | ||
| Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride | Q70059150 | ||
| Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sections | Q70215325 | ||
| [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations | Q70864042 | ||
| Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride | Q71302739 | ||
| Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain | Q71673863 | ||
| [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors | Q72147800 | ||
| [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey | Q72750881 | ||
| Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635 | Q73083040 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 715-719 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Nuclear Medicine and Biology | Q7067979 |
| P1476 | title | Whole hemisphere autoradiography of the postmortem human brain | |
| P478 | volume | 25 |
| Q35179039 | Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain |
| Q44934932 | Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain |
| Q31485676 | Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. |
| Q34093061 | Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. |
| Q48906405 | Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11 C]T-773 in nonhuman primates |
| Q38810544 | Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging |
| Q48556074 | Continuous monitoring of post mortem temperature changes in the human brain |
| Q42461333 | Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain |
| Q34218138 | Distribution of 5-HT4 receptors in the postmortem human brain--an autoradiographic study using [125I]SB 207710. |
| Q43590739 | Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics |
| Q44593446 | Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography |
| Q41042051 | Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography |
| Q74272023 | GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain |
| Q33275232 | In vitro imaging techniques in neurodegenerative diseases |
| Q44010230 | Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study |
| Q44770681 | Neuroimaging of mirtazapine enantiomers in humans |
| Q37220469 | Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628. |
| Q43570136 | New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey |
| Q37164698 | PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter |
| Q44916198 | PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain |
| Q49068435 | Regional expression of 5-HT1B receptor mRNA in the human brain |
| Q44589880 | Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. |
| Q36491700 | Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1. |
| Q44007077 | Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor |
| Q34267133 | The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ an |
Search more.